MedTrace Logo

Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)

NCT00700999 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2014-06-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine if treatment of post-traumatic stress disorder in combat veterans with paroxetine changes brain responses as measured by functional magnetic resonance imaging and if brain responses can predict who will get better with treatment.

Conditions

  • Post-traumatic Stress Disorder

Interventions

DRUG

Paroxetine

Paroxetine 20-40mg po QD for 12 weeks

Sponsors & Collaborators

Principal Investigators

  • K. Luan Phan, MD · Jesse Brown VA Medical Center, Chicago, IL

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700999 on ClinicalTrials.gov